GLASSIA Trademark

Trademark Overview

On Tuesday, February 2, 2010, a trademark application was filed for GLASSIA with the United States Patent and Trademark Office. The USPTO has given the GLASSIA trademark a serial number of 77925761. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, May 4, 2022. This trademark is owned by KAMADA LTD.. The GLASSIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, alpha-1 proteinase inhibitor
glassia

General Information

Serial Number77925761
Word MarkGLASSIA
Filing DateTuesday, February 2, 2010
Status800 - REGISTERED AND RENEWED
Status DateWednesday, May 4, 2022
Registration Number3871558
Registration DateTuesday, November 2, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, alpha-1 proteinase inhibitor

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 11, 2010
Primary Code005
First Use Anywhere DateFriday, August 21, 2009
First Use In Commerce DateFriday, August 21, 2009

Trademark Owner History

Party NameKAMADA LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRehovot 7670402
IL
Party NameKAMADA LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNess Ziona 74036
IL
Party NameKAMADA LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNess Ziona 74036
IL

Trademark Events

Event DateEvent Description
Thursday, May 5, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 4, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, May 4, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 15, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, March 27, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, January 21, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 28, 2020TEAS SECTION 8 & 9 RECEIVED
Saturday, November 2, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 25, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 25, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 25, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 14, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 2, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, September 29, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 28, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, September 28, 2010ASSIGNED TO LIE
Monday, September 20, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, September 2, 2010STATEMENT OF USE PROCESSING COMPLETE
Monday, August 9, 2010USE AMENDMENT FILED
Thursday, September 2, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 9, 2010TEAS STATEMENT OF USE RECEIVED
Thursday, July 8, 2010ASSIGNED TO EXAMINER
Tuesday, June 29, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 4, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2010PUBLISHED FOR OPPOSITION
Saturday, March 27, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 27, 2010ASSIGNED TO LIE
Thursday, March 11, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 11, 2010ASSIGNED TO EXAMINER
Thursday, February 11, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 5, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

glassia proteinase inhibitor alpha namely preparations pharmaceutical